Is Olanzapine Effective for Bipolar Mixed Features Management?
Share this post
Bipolar disorder’s mixed episode (per DSM IV) classification was changed to mixed feature specifier in DSM-5. Diagnosing manic and depressive phases in bipolar disorder can be comparatively easier compared to the diagnosis of mixed features.
The following video from our Bipolar Disorder Update 2020 conference will summarize the role of Olanzapine in the following mixed phases management in bipolar disorder:
- ACUTE treatment: Manic Mixed.
- ACUTE treatment: Depression Mixed.
- MAINTENANCE treatment: preventing Depression after mixed.
- MAINTENANCE treatment: preventing Mania after mixed.
- MAINTENANCE treatment: preventing any episode after mixed.
WATCH VIDEO DISCUSSION:
COMPLETE CONFERENCE PRESENTATION
INCLUDES FOLLOWING TOPICS:
- What are the diagnostic criteria for mixed feature specifier in DMS-5?
- Understanding the changes in DSM-5 mixed feature specifier compared to DSM-IV-TR mixed episode diagnosis.
- Why is diagnosing mixed specifier clinically important?
- Which assessment scales can be used to diagnose mixed feature specifier?
- Discussing the management options for mixed features in bipolar disorder, including a discussion of 20 treatment options.
INTERESTED IN LEARNING MORE?
JOIN OUR CONFERENCE:
PSYCHIATRY EDUCATION FORUM'S
SECOND ONLINE CME CONFERENCE:
BIPOLAR DISORDER UPDATE 2020
We guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.
RELEASED ON: DEC 15, 2020
(WITH LIFETIME ACCESS)
Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your clinical decision-making. We are enthralled to release our second online CME conference. Once again, we guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.
Our second conference focuses exclusively on one of the most important aspects of your practice:
Managing Various Aspects of Bipolar Disorder.
CONFERENCE INTRODUCTION VIDEO:
8.75 AMA PRA Category 1 Credits Available
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Psychiatry Education Forum LLC. PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.